Evidence map›Paper›PMID 31239240›Full record

ArticleClinical genitourinary cancer2019

Racial and Socioeconomic Disparities in Bladder Cancer Survival: Analysis of the California Cancer Registry.

John M Sung, Jeremy W Martin, Francis A Jefferson, Daniel A Sidhom, Keyhan Piranviseh, Melissa Huang, Nobel Nguyen, Jenny Chang, Argyrios Ziogas, Hoda Anton-Culver and 1 more

Abstract read
In one paragraph

Article in Clinical genitourinary cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Article
  2. Article
  3. Genomic Characteristics of Bladder Cancer: An AACR Project GENIE Study.International journal of molecular sciences · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Comparison of primary payer in cancer registry and discharge data.The American journal of managed care · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

John M SungDepartment of Urology, University of California, Irvine, CA. Electronic address: jsung@medicine.tamhsc.edu.
Jeremy W MartinDepartment of Urology, University of California, Irvine, CA.
Francis A JeffersonDepartment of Urology, University of California, Irvine, CA.
Daniel A SidhomDepartment of Urology, University of California, Irvine, CA.
Keyhan PiranvisehDepartment of Urology, University of California, Irvine, CA.
Melissa HuangDepartment of Urology, University of California, Irvine, CA.
Nobel NguyenDepartment of Urology, University of California, Irvine, CA.
Jenny ChangDepartment of Epidemiology, University of California, Irvine, CA.
Argyrios ZiogasDepartment of Epidemiology, University of California, Irvine, CA.
Hoda Anton-CulverDepartment of Epidemiology, University of California, Irvine, CA.
Ramy F YoussefDepartment of Urology, University of California, Irvine, CA.

Funding

Univ.of Calif., Irvine Cancer Center Support GrantP30CA062203 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI Christine Hui · 1994 to 2026
$57.9M
NCI NIH HHS P30 CA062203
6 · The paper itself

Abstract

purposeTo examine the California Cancer Registry (CCR) for bladder cancer survival disparities based on race, socioeconomic status (SES), and insurance in California patients. PATIENTS AND

methodsThe CCR was queried for bladder cancer cases in California from 1988 to 2012. The primary outcome was disease-specific survival (DSS), defined as the time interval from date of diagnosis to date of death from bladder cancer. Survival analyses were performed to determine the prognostic significance of racial and socioeconomic factors.

resultsA total of 72,452 cases were included (74.5% men, 25.5% women). The median age was 72 years (range, 18-109 years). The racial distribution among the patients was 81% white, 3.8% black, 8.8% Hispanic, 5.2% Asian, and 1.2% from other races. In black patients, tumors presented more frequently with advanced stage and high grade. Medicaid patients tended to be younger and had more advanced-stage, higher-grade tumors compared to patients with Medicare or managed care (P < .0001). Kaplan-Meier analysis demonstrated significantly poorer 5-year DSS in black, low SES, and Medicaid patients (P < .0001). When controlling for stage, grade, age, and gender, multivariate analysis revealed that black race (DSS hazard ratio = 1.295; 95% confidence interval, 1.212-1.384), low SES (DSS hazard ratio = 1.325; 95% confidence interval, 1.259-1.395), and Medicaid insurance (DSS hazard ratio = 1.349; 95% confidence interval, 1.246-1.460) were independent prognostic factors (P < .0001).

conclusionAn analysis of the CCR demonstrated that black race, low SES, and Medicaid insurance portend poorer DSS. These findings reflect a multifaceted socioeconomic and public health conundrum, and efforts to reduce inequalities should be pursued.

Indexed as

AdultAgedAged, 80 and overCaliforniaFemaleHealthcare DisparitiesHealth Status DisparitiesHumansMaleMiddle AgedMortalityNeoplasm GradingNeoplasm StagingPrognosisRegistriesSocioeconomic FactorsDisease-specific survivalInsuranceRaceSocioeconomic status

Identifiers

PMID31239240
PMCPMC7821748

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.